is glp-1 a biologic Frontiers Enhanced plasma half-life and efficacy

The brand-name semaglutide options include: Ozempic: FDA-approved for type 2 diabetes, though often prescribed off-label for weight loss Wegovy: A higher-dose version of semaglutide specifically FDA-approved for chronic weight management Rybelsus: The only oral form of semaglutide, FDA-approved for type 2 diabetes The brand name tirzepatide options include: Mounjaro: FDA-approved for type 2 diabetes, though often prescribed off-label for weight loss Zepbound: FDA-approved for weight loss in qualifying patients The brand name liraglutide options include: Saxenda: FDA-approved for chronic weight management Zepbound is available in two forms: vials and pens

Competing interests The authors declare no competing interests

2013;36(10):e1712

*** No reference values available

The Oral route of administration segment is anticipated to be the fastest-growing category with a CAGR of 10.2% from 2026 to 2033, driven by growing patient preference for non-injectable therapies, improving treatment compliance, and ongoing advancements in oral peptide drug delivery technologies